Form 483

KBD Inc DBA Sperti Sunlamp Form 483, 2012-08-22

FDA issued a Form 483 to KBD Inc DBA Sperti Sunlamp on 2012-08-22 with 5 public-safe observations.

483· Form 483 issued5 observations

KBD Inc DBA Sperti Sunlamp · North Las Vegas, United States · Issued August 22, 2012

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Aug 2012
21 CFR 820.30(c)

Design input - documentation

Cited by Christine E Kelley, Maribeth G Grattan

22 Aug 2012
21 CFR 820.30(g)

Design validation - Risk analysis

Cited by Christine E Kelley, Maribeth G Grattan

22 Aug 2012
21 CFR 820.30(i)

Design changes - Lack of or Inadequate Procedures

Cited by Christine E Kelley, Maribeth G Grattan

22 Aug 2012
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Christine E Kelley, Maribeth G Grattan

22 Aug 2012
21 CFR 820.198(b)

Review and evaluation for investigation

Cited by Christine E Kelley, Maribeth G Grattan

Inspected site

KIKBD Inc DBA Sperti SunlampNorth Las Vegas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(c)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere